TABLE 3.

MetS components by treatment allocation and maternal genotype of SNP rs174602 (n = 314).

	Treatment group		Maternal genotype
	Placebo	DHA	CC	TC	TT
	N = 154	N = 160	N = 127	N = 143	N = 44
Glucose (mg/dL)	88.2 (86.9, 89.5)	87.3 (86.0, 88.6)	86.6 (85.1, 88.1)	88.3 (87.0, 89.6)	89.0 (86.6, 91.4)
HDL (mg/dL)	46.9 (45.1, 48.6)	46.0 (44.3, 47.8)	45.8 (43.8, 47.7)	46.5 (44.7, 48.2)	48.4 (45.2, 51.6)
Triglycerides (mg/dL)	104 (94.3, 113)	111 (101.7, 120)	113 (102.7, 123)	104 (94.2, 113)	103 (85.5, 120)
SBP (mmHg)	103 (101, 104)	102 (101, 104)	103 (101.6, 105)	102 (100.5, 103)	102 (99.1, 104)
BMI-z score	0.64 (0.43, 0.85)	0.69 (0.49, 0.91)	0.88 (0.65, 1.12)	0.55 (0.22, 0.76)	0.48 (0.08, 0.87)
MetS score	-0.01 (-0.10, 0.07)	0.01 (-0.08, 0.09)	0.06 (-0.03, 0.16)	-0.04 (-0.12, 0.05)	-0.07 (-0.22, 0.08)

Values presented are adjusted means (95% CI).

SBP, systolic blood pressure; MetS, metabolic syndrome.